2016-11-23
The results of our latest collaboration are published in Hepatology.
With Dr Karvellas from the University of Alberta, we studied a new biomarker, FABP1 (fatty acid binding protein 1) in the serum of patients with acute liver failure induced by acetaminophen. In survivor patients, we detected a lower rate of FABP1.
This first study on FABP1 could possibly allow discrimination between survivors of non-survivors, aiming to improve clinical practice.
Related Publication
U. S. Acute Liver Failure Study Group, Constantine J. Karvellas, Jaime L. Speiser, Mélanie Tremblay, William M. Lee, Christopher F. Rose, U. S. Acute Liver Failure Study Group.
